BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17931740)

  • 1. Minimal deletion regions in lung squamous cell carcinoma: association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers.
    Tseng RC; Hsieh FJ; Hsu HS; Wang YC
    Lung Cancer; 2008 Mar; 59(3):332-9. PubMed ID: 17931740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer.
    Lee MN; Tseng RC; Hsu HS; Chen JY; Tzao C; Ho WL; Wang YC
    Clin Cancer Res; 2007 Feb; 13(3):832-8. PubMed ID: 17289874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome bands 3p14.2, 9p21, and 13q14 are frequently deleted in roentgenographically occult bronchogenic squamous cell carcinoma of the lung.
    Sato M; Sakurada A; Sagawa M; Endo C; Tanita T; Kondo T; Tsuchiya E; Fujimura S; Horii A
    Genes Chromosomes Cancer; 1998 Dec; 23(4):367-70. PubMed ID: 9824211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.
    Kang JU; Koo SH; Kwon KC; Park JW
    Int J Oncol; 2010 Aug; 37(2):327-35. PubMed ID: 20596660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.
    Tseng RC; Chang JW; Hsien FJ; Chang YH; Hsiao CF; Chen JT; Chen CY; Jou YS; Wang YC
    Int J Cancer; 2005 Nov; 117(2):241-7. PubMed ID: 15900585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung.
    Petersen S; Rudolf J; Bockmühl U; Gellert K; Wolf G; Dietel M; Petersen I
    Oncogene; 1998 Jul; 17(4):449-54. PubMed ID: 9696038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
    Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
    Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma.
    Qin YR; Fu L; Sham PC; Kwong DL; Zhu CL; Chu KK; Li Y; Guan XY
    Int J Cancer; 2008 Aug; 123(4):826-30. PubMed ID: 18508313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
    Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
    Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
    Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China.
    Huang J; Hu N; Goldstein AM; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang QH; Dawsey SM; Han XY; Ding T; Li G; Giffen C; Taylor PR
    Carcinogenesis; 2000 Nov; 21(11):2019-26. PubMed ID: 11062163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity in mammary serine protease inhibitor (maspin) and p53 at chromosome 17 and 18 in oral cavity squamous cell carcinoma.
    Choi KY; Choi HJ; Chung EJ; Lee DJ; Kim JH; Rho YS
    Head Neck; 2015 Sep; 37(9):1239-45. PubMed ID: 24801268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma.
    Shin JH; Kang SM; Kim YS; Shin DH; Chang J; Kim SK; Kim SK
    Chest; 2005 Oct; 128(4):2999-3003. PubMed ID: 16236978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.